SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001159036-20-000044
Filing Date
2020-11-02
Accepted
2020-11-02 16:11:02
Documents
72
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q haloq320-10q.htm   iXBRL 10-Q 1781297
2 EXHIBIT 31.1 ex31110qq32020.htm EX-31.1 17452
3 EXHIBIT 31.2 ex31210qq32020.htm EX-31.2 17479
4 EXHIBIT 32 ex3210qq32020.htm EX-32 20711
10 slide1b46.jpg GRAPHIC 413470
11 slide2b29.jpg GRAPHIC 93357
  Complete submission text file 0001159036-20-000044.txt   9282724

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT halo-20200930.xsd EX-101.SCH 43282
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT halo-20200930_cal.xml EX-101.CAL 86127
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT halo-20200930_def.xml EX-101.DEF 210529
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT halo-20200930_lab.xml EX-101.LAB 598817
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT halo-20200930_pre.xml EX-101.PRE 364393
12 EXTRACTED XBRL INSTANCE DOCUMENT haloq320-10q_htm.xml XML 1535400
Mailing Address 11388 SORRENTO VALLEY ROAD SAN DIEGO CA 92121-1345
Business Address 11388 SORRENTO VALLEY ROAD SAN DIEGO CA 92121-1345 (858) 794-8889
HALOZYME THERAPEUTICS, INC. (Filer) CIK: 0001159036 (see all company filings)

IRS No.: 880488686 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32335 | Film No.: 201280566
SIC: 2836 Biological Products, (No Diagnostic Substances)